The DOI matches its Crossref record.
FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study
Open accessAbstract
BACKGROUND: In preclinical gastric cancer (GC) models, FGFR2 amplification was associated with increased tumour cell proliferation and survival, and drugs targeting this pathway are now in clinical trials. METHODS: FGFR2 FISH was performed on 961 GCs from the United Kingdom, China and Korea, and the relationship with clinicopathological data and overlap with HER2 amplification were analysed. RESULTS: The prevalence of FGFR2 amplification was similar between the three cohorts (UK 7.4%, China 4.6% and Korea 4.2%), and intratumoral heterogeneity was observed in 24% of FGFR2 amplified cases. FGFR2 amplification was associated with lymph node metastases (P<0.0001). FGFR2 amplification and polysomy were associated with poor overall survival (OS) in the Korean (OS: 1.83 vs 6.17 years, P=0.0073) and UK (OS: 0.45 vs 1.9 years, P<0.0001) cohorts, and FGFR2 amplification was an independent marker of poor survival in the UK cohort (P=0.0002). Co-amplification of FGFR2 and HER2 was rare, and when high-level amplifications did co-occur these were detected in distinct areas of the tumour. CONCLUSION: A similar incidence of FGFR2 amplification was found in Asian and UK GCs and was associated with lymphatic invasion and poor prognosis. This study also shows that HER2 and FGFR2 amplifications are mostly exclusive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Machlowska, J., Baj, J., Sitarz, M., Maciejewski, R., & Sitarz, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114012 · Cited by 1,520
FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
KATOH, M. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2620 · Cited by 405
FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data
Nicorici, D., Şatalan, M., Edgren, H., Kangaspeska, S., Murumägi, A., Kallioniemi, O., Virtanen, S., & Kilkku, O. (2014) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/011650 · Cited by 388
Metadata
- Authors
- Su, X., Zhan, P., Gavine, P. R., Morgan, S., Womack, C., Ni, X., Shen, D., Bang, Y.-J., Im, S.-A., Ho Kim, W., Jung, E.-J., Grabsch, H. I., & Kilgour, E.
- Venue
- British Journal of Cancer
- Published
- 2014-01-23
- Volume
- 110
- Issue
- 4
- Pages
- 967-975
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2005792607
- Cited by
- 190
- References
- 0
- FWCI
- 18.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. https://app.cochat.ai/papers/10.1038/bjc.2013.802
- The paper
- Su, X., Zhan, P., Gavine, P. R., Morgan, S., Womack, C., Ni, X., Shen, D., Bang, Y.-J., Im, S.-A., Ho Kim, W., Jung, E.-J., Grabsch, H. I., & Kilgour, E. (2014). FGFR2 amplification has prognostic significance in gastric cancer: results from a large international multicentre study. British Journal of Cancer. https://doi.org/10.1038/bjc.2013.802
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.